Delineate
Agents for Accelerated Clinical Trial Design
Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.
- Website
- delineate.pro
- City
- Boston
- Country
- United States
- YC batch
- Winter 2025
- Team
- 20 people
- Stage
- Early stage
- AI-native
- Yes
More Health & bio in Boston
WHOOP$10.1bn
Wearable technology. Valued at $10.1bn (March 2026).
Ginkgo BioworksHiring
Our mission is to make biology easier to engineer.
Modern HealthHiring
A mental health benefits platform for employers.
TetraScience
The only R&D data cloud for life sciences
OpenBiome
A nonprofit stool bank enabling access to fecal transplants.
SiPhox HealthHiring
At-Home health monitoring with silicon photonic chips for data centers
Claim this profile
Free and instant: prove you run delineate.pro and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Delineate across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Delineate's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
